HC Wainwright Issues Pessimistic Forecast for CORT Earnings
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – HC Wainwright reduced their Q1 2025 earnings per share estimates for Corcept Therapeutics in a research note issued on Thursday, February 27th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings of $0.16 per share for the quarter, down from their prior […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – HC Wainwright reduced their Q1 2025 earnings per share estimates for Corcept Therapeutics in a research note issued on Thursday, February 27th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings of $0.16 per share for the quarter, down from their prior […]
